WHO adds BioFire® Global Fever Special Pathogens Panel to Emergency Use Listing — 19 October 2026
Event summary
On 19 October 2026 WHO's Prequalification office added the BioFire® Global Fever Special Pathogens Panel to the Emergency Use Listing (EUL). The WHO notice states the product "has been assessed only for Ebolavirus/BDBV detection claims."
CHRONOS Wire · October 20 · Alert 6
Publication details
- Published
- Updated
- Revision
- r1
- Source
- WHO Prequalification (extranet.who.int)
Cliff Notes
- WHO added the BioFire® Global Fever Special Pathogens Panel to the EUL on 19 Oct 2026; the EUL assessment is limited to Ebolavirus/BDBV detection claims.
U.S. Impact
U.S. Impact assessment pending.
ELI5: Plain-English Explanation
On 19 October 2026, WHO added the BioFire® Global Fever Special Pathogens Panel to its Emergency Use Listing (EUL). WHO's notice says the product "has been assessed only for Ebolavirus/BDBV detection claims."
Why Urgent Level 3
The EUL listing is newly published and relevant to stakeholders planning BDBV testing capacity and procurement.
What Changed
WHO's Prequalification office posted on 19 October 2026 that it added the BioFire® Global Fever Special Pathogens Panel to the Emergency Use Listing (EUL). The EUL assessment explicitly covers only Ebolavirus/BDBV detection claims under the current listing.
What Is Genuinely New
WHO formally added the BioFire® Global Fever Special Pathogens Panel to the Emergency Use Listing on 19 October 2026, and the listing notes assessment only for Ebolavirus/BDBV detection claims.
CHRONOS Bottom Line
WHO added the BioFire® Global Fever Special Pathogens Panel to the EUL on 19 October 2026; the WHO notice specifies that the current EUL assessment covers only Ebolavirus/BDBV detection claims.
Uncertainties / Known Unknowns
The WHO notice limits the EUL assessment to Ebolavirus/BDBV and does not specify specimen types, other pathogen claims, or timelines for national regulatory acceptance, procurement, or operational deployment.
Detailed Analysis
WHO publicly announced on 19 October 2026 that it added the BioFire® Global Fever Special Pathogens Panel to its Emergency Use Listing (EUL). The announcement explicitly states that "under the current EUL, the product has been assessed only for Ebolavirus/BDBV detection claims." The source does not provide information about national regulatory status, procurement decisions, specimen types, or expanded claims beyond Ebolavirus/BDBV.
Sources / Evidence
- 01WHO adds BioFire® Global Fever Special Pathogens Panel to EULWHO Prequalification (extranet.who.int)2026-10-19
Follow CHRONOS ALERTS
Published alerts also appear on Instagram and Threads as @chronosalerts.